EL
Elicio Therapeutics, Inc. (ELTX)
NASDAQ·Healthcare·Biotechnology
$10.84
-4.58%
Mkt Cap $203.31M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+56.8%
Consensus $17.00 vs current $10.84
NASDAQ·Healthcare·Biotechnology
$10.84
-4.58%
Mkt Cap $203.31M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $17.00 – $17.00
+56.8%
Consensus $17.00 vs current $10.84